The Tyzeka scripts are for the US only, so its hard to say what the sales uptake looks like in other countries. We’ll just have to wait for IDIX’s 2Q08 financials, which will include royalties based on NVS’ sales during the prior quarter (1Q07).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”